Benzonatate Capsule
Product Images NDC 69452-143

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Benzonatate (NDC 69452-143). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bionpharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Image001)

Chemical structure diagram of Benzonatate, showing its molecular formula components and structural representation with chemical groups and bonds.*

FDA Label Image

100 mg Bottle Label (Image002v2)

Benzonatate Capsules, USP 100 mg soft gelatin capsules label by Bionpharma Inc. The label includes the NDC 69452-143-20, storage instructions to protect from light, and a warning to keep out of reach of children. The label is primarily white with black and red text and features a space for serialization on the right side.*

FDA Label Image

200 mg Bottle Label (Image003v2)

Benzonatate Capsules, USP 200 mg soft gelatin capsules label from Bionpharma Inc. The label includes NDC 69452-144-20 and states 100 soft gelatin capsules in the container. It provides storage instructions to protect from light and keep out of reach of children, with dosage directions to see accompanying professional information. Manufacturer details and a space for serialization are also shown.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.